/
Your selections:
The Prognostic Utility of KRAS Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients
- Petit, Joel, Carroll, Georgia, Zhao, Jie, Pockney, Peter, Scott, Rodney J.
Therapeutic targeting of heat shock protein 90 in human colon cancer cells
- Wang, Chunyan
Inhibition of HSP90 by AUY922 preferentially kills mutant KRAS colon cancer cells by activating Bim through ER stress
- Wang, Chun Yan, Guo, Su Tang, Wang, Jia Yu, Liu, Fen, Zhang, Yuan Yuan, Yari, Hamed, Yan, Xu Guang, Jin, Lei, Zhang, Xu Dong, Jiang, Chen Chen
KRAS mutation testing in colorectal cancer: the model for molecular pathology testing in the future
- Wong, Stephen Q., Scott, Rodney, Fox, Stephen B.
Current opinion on optimal treatment for colorectal cancer
- Price, Timothy J., Segelov, Eva, Shapiro, Jeremy D., Burge, Matthew, Haller, Daniel G., Ackland, Stephen P., Tebbutt, Niall C., Karapetis, Christos S., Pavlakis, Nick, Sobrero, Alberto F., Cunningham, David
Are you sure you would like to clear your session, including search history and login status?